Gerresheimer (GXI) PT Set at €72.00 by Credit Suisse Group

Gerresheimer (ETR:GXI) received a €72.00 ($88.89) target price from equities researchers at Credit Suisse Group in a report issued on Monday. The firm presently has a “buy” rating on the stock. Credit Suisse Group’s price target would suggest a potential upside of 7.54% from the company’s previous close.

A number of other equities analysts have also recently issued reports on the stock. Hauck & Aufhaeuser set a €52.50 ($64.81) target price on shares of Gerresheimer and gave the stock a “sell” rating in a research report on Friday, April 13th. Deutsche Bank restated a “neutral” rating on shares of Gerresheimer in a research report on Friday, April 13th. Independent Research set a €68.00 ($83.95) target price on shares of Gerresheimer and gave the stock a “neutral” rating in a research report on Thursday, April 12th. Commerzbank set a €68.00 ($83.95) target price on shares of Gerresheimer and gave the stock a “neutral” rating in a research report on Thursday, April 12th. Finally, Berenberg Bank set a €78.00 ($96.30) target price on shares of Gerresheimer and gave the stock a “buy” rating in a research report on Thursday, April 12th. Two analysts have rated the stock with a sell rating, eight have issued a hold rating and three have issued a buy rating to the stock. The stock presently has an average rating of “Hold” and an average price target of €67.96 ($83.90).

How to Become a New Pot Stock Millionaire

Shares of GXI opened at €66.95 ($82.65) on Monday. Gerresheimer has a 12-month low of €59.97 ($74.04) and a 12-month high of €78.25 ($96.60).

ILLEGAL ACTIVITY NOTICE: “Gerresheimer (GXI) PT Set at €72.00 by Credit Suisse Group” was originally posted by StockNewsTimes and is owned by of StockNewsTimes. If you are accessing this piece of content on another publication, it was illegally stolen and republished in violation of U.S. & international copyright & trademark law. The legal version of this piece of content can be accessed at https://stocknewstimes.com/2018/04/18/gerresheimer-gxi-pt-set-at-72-00-by-credit-suisse-group.html.



Gerresheimer Company Profile

Gerresheimer AG manufactures and sells specialty glass and plastic products primarily for the pharma and healthcare industry worldwide. It operates through two divisions, Plastics & Devices, and Primary Packaging Glass. The Plastics & Devices division offers drug delivery systems, including inhalers, pen systems, and injection systems; sterile and non-sterile prefillable syringe systems for the pharmaceutical and biotech industries; and disposables for various analysis systems that are used in laboratories and medical practices, quick tests for patients in medical practices or hospitals, skin-prick aids and lancets for diabetics, disposables and components for dialysis machines, and catheters and surgical devices.

Analyst Recommendations for Gerresheimer (ETR:GXI)

Receive News & Ratings for Gerresheimer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gerresheimer and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply